Search results
US approves Moderna's RSV vaccine for older adults
Alaska Superstation· 6 days agoThe US Food and Drug Administration on Friday approved Moderna's respiratory syncytial virus (RSV) vaccine for older adults -- marking the first time any...
FDA Advisers Urge Targeting JN.1 Strain in Recipe for Fall's COVID Vaccines
US News & World Report· 8 hours agoGovernment advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines Americans will receive in the fall -- targeting a version of the ever-evolving coronavirus called ...
FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines
Stamford Advocate· 6 hours agoGovernment advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines...
Why Is Novavax (NVAX) Stock Up 20% Today?
InvestorPlace· 9 hours agoNovavax (NASDAQ:NVAX) is on a recovery trek after collapsing in late 2021. Regarding timeline, the latter two firms said that they would be able to...
US approves Moderna’s RSV vaccine for older adults | FOX 28 Spokane
FOX 28 Spokane· 6 days agoThe US Food and Drug Administration on Friday approved Moderna’s respiratory syncytial virus (RSV)...
This Nobel Prize-winning scientist breaks down the future of RNA and CRISPR technology | CNN
CNN.com· 17 hours agoWhile you’re probably pretty familiar with DNA, it’s likely that RNA only made it onto your radar...
Salesforce, Kohl's and Agilent fall premarket; Foot Locker, Moderna rise By Investing.com
Investing.com· 7 days agoSalesforce, Kohl's and Agilent fall premarket; Foot Locker, Moderna rise
FDA advisers urge targeting JN.1 strain for fall’s COVID vaccines
Marshall Independent· 43 minutes agoGovernment advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines Americans will receive in the fall — targeting a version of the ever-evolving coronavirus called JN ...
Merck, Moderna Drug Combo Shows Improved Survival in Skin Cancer Trial
Morningstar· 3 days agoModerna and Merck said they saw positive results from a Phase 2b study evaluating mRNA-4157 in combination with Keytruda in patients with high-risk skin cancer that was surgically ...
Moderna, Merck Reveal Three Year Data For Individualized Cancer Therapy In High-Risk Melanoma...
Benzinga· 3 days agoMonday, Moderna Inc MRNA and Merck & Co Inc MRK announced the first presentation of results from a planned analysis from the Phase 2b KEYNOTE-942/mRNA-4157-P201 study. The ...